Cargando…
Comparative efficacy of modified FOLFIRINOX, gemcitabine plus capecitabine and gemcitabine plus nab-paclitaxel as adjuvant treatment for resected pancreatic cancer: a Bayeasian network meta-analysis
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cancer Intelligence
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580714/ https://www.ncbi.nlm.nih.gov/pubmed/34824628 http://dx.doi.org/10.3332/ecancer.2021.1305 |
| _version_ | 1784596660385480704 |
|---|---|
| author | de Jesus, Victor Hugo Fonseca Riechelmann, Rachel P |
| author_facet | de Jesus, Victor Hugo Fonseca Riechelmann, Rachel P |
| author_sort | de Jesus, Victor Hugo Fonseca |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8580714 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Cancer Intelligence |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85807142021-11-24 Comparative efficacy of modified FOLFIRINOX, gemcitabine plus capecitabine and gemcitabine plus nab-paclitaxel as adjuvant treatment for resected pancreatic cancer: a Bayeasian network meta-analysis de Jesus, Victor Hugo Fonseca Riechelmann, Rachel P Ecancermedicalscience Erratum Cancer Intelligence 2021-10-12 /pmc/articles/PMC8580714/ /pubmed/34824628 http://dx.doi.org/10.3332/ecancer.2021.1305 Text en © the authors; licensee ecancermedicalscience. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Erratum de Jesus, Victor Hugo Fonseca Riechelmann, Rachel P Comparative efficacy of modified FOLFIRINOX, gemcitabine plus capecitabine and gemcitabine plus nab-paclitaxel as adjuvant treatment for resected pancreatic cancer: a Bayeasian network meta-analysis |
| title | Comparative efficacy of modified FOLFIRINOX, gemcitabine plus capecitabine and gemcitabine plus nab-paclitaxel as adjuvant treatment for resected pancreatic cancer: a Bayeasian network meta-analysis |
| title_full | Comparative efficacy of modified FOLFIRINOX, gemcitabine plus capecitabine and gemcitabine plus nab-paclitaxel as adjuvant treatment for resected pancreatic cancer: a Bayeasian network meta-analysis |
| title_fullStr | Comparative efficacy of modified FOLFIRINOX, gemcitabine plus capecitabine and gemcitabine plus nab-paclitaxel as adjuvant treatment for resected pancreatic cancer: a Bayeasian network meta-analysis |
| title_full_unstemmed | Comparative efficacy of modified FOLFIRINOX, gemcitabine plus capecitabine and gemcitabine plus nab-paclitaxel as adjuvant treatment for resected pancreatic cancer: a Bayeasian network meta-analysis |
| title_short | Comparative efficacy of modified FOLFIRINOX, gemcitabine plus capecitabine and gemcitabine plus nab-paclitaxel as adjuvant treatment for resected pancreatic cancer: a Bayeasian network meta-analysis |
| title_sort | comparative efficacy of modified folfirinox, gemcitabine plus capecitabine and gemcitabine plus nab-paclitaxel as adjuvant treatment for resected pancreatic cancer: a bayeasian network meta-analysis |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580714/ https://www.ncbi.nlm.nih.gov/pubmed/34824628 http://dx.doi.org/10.3332/ecancer.2021.1305 |
| work_keys_str_mv | AT dejesusvictorhugofonseca comparativeefficacyofmodifiedfolfirinoxgemcitabinepluscapecitabineandgemcitabineplusnabpaclitaxelasadjuvanttreatmentforresectedpancreaticcancerabayeasiannetworkmetaanalysis AT riechelmannrachelp comparativeefficacyofmodifiedfolfirinoxgemcitabinepluscapecitabineandgemcitabineplusnabpaclitaxelasadjuvanttreatmentforresectedpancreaticcancerabayeasiannetworkmetaanalysis |